Quick answer CJC-1295 and Ipamorelin are synthetic peptides that stimulate the body’s own release of growth hormone, often used together (‘stacked’). They are not approved standard medicines. Human evidence is limited, and any use is off-label. Regulators have flagged safety concerns and restricted their compounding, and a long-acting version of CJC-1295 was discontinued after a serious trial event. Because of this, they should only ever be considered under strict medical supervision, never self-sourced — and they are banned in sport.

CJC-1295 and Ipamorelin are among the most-discussed ‘growth hormone’ peptides. This is an honest look at what they are and the facts that matter. For the wider view, see our peptide therapy guide.

What are CJC-1295 and Ipamorelin?

Both are synthetic peptides that act on the system controlling growth hormone (GH). CJC-1295 is an analogue of growth-hormone-releasing hormone (GHRH), which signals the pituitary gland to produce GH. Ipamorelin works through a different receptor (mimicking ghrelin) to prompt a more immediate release of GH. The idea behind combining them is that acting on two complementary pathways may produce a more natural GH pulse than either alone.

Why are they used together?

Because they stimulate GH release through two different mechanisms, they are frequently ‘stacked’ in the hope of a stronger, more physiological effect. People are typically drawn to them for recovery, body composition, sleep and anti-ageing goals. It is important to stress that these are aspirations based largely on mechanism and anecdote, not on robust human outcome data.

What does the evidence show?

• Limited human data. Clinical evidence is limited and often confined to small studies or short durations; there are no long-term human outcome trials.
• Off-label and unapproved. They are not approved medicines for these uses, so any use is off-label and outside standard regulatory approval.
• Mechanism is not proof. A plausible mechanism for raising GH does not establish safe, meaningful benefits for the goals people pursue.

The honest bottom line CJC-1295 and Ipamorelin can raise growth hormone, but proven, safe long-term benefits in humans are not established. Much of what is claimed online rests on mechanism and anecdote, not high-quality trials. The regulatory and safety context (below) is a major part of the picture — not a footnote.

Regulatory and safety facts

This is essential to understand before considering these peptides:

• Compounding restricted. Regulators including the US FDA have designated CJC-1295 and Ipamorelin as substances flagged for significant risks in compounding, effectively restricting their preparation for human use in that setting.
• A serious trial signal. A long-acting (DAC) version of CJC-1295 was discontinued after a death occurred during clinical development, and long-term safety data are lacking.
• Reported adverse effects. Concerns raised include effects such as increased heart rate and vasodilatory reactions, with clinical data described as limited.
• Banned in sport. Growth-hormone secretagogues are prohibited for competitive athletes.

If you are considering these peptides Never buy or self-administer them from online or informal sources. Only ever consider them under a physician who knows your full history, with monitoring. Avoid entirely if you are a competitive athlete, pregnant, or have a history of cancer or significant heart disease.

The responsible approach

At My-Health, peptides are only considered after a physician review, prescribed and monitored medically, and compounded through a DHA-licensed pharmacy — with honesty about the limits of the evidence and the regulatory context. See the full peptide therapy guide or the BPC-157 guide.

Facts before hype Curious about growth-hormone peptides? Get an honest, physician-led assessment rather than an online promise. My-Health offers supervised peptide care in Dubai. Visit my-health.ae.

Frequently asked questions

What do CJC-1295 and Ipamorelin do?

They are synthetic peptides that stimulate the body’s own release of growth hormone through two different mechanisms, which is why they are often combined.

Are CJC-1295 and Ipamorelin safe?

Their long-term safety in humans is not established. Regulators have flagged concerns and restricted compounding, and a long-acting version of CJC-1295 was discontinued after a serious trial event. They should only be considered under medical supervision.

Are they FDA-approved?

No. They are not approved medicines for these uses, and regulators have flagged them as compounding risks. Any use is off-label.

Are they banned in sport?

Yes. Growth-hormone secretagogues are prohibited for competitive athletes, so their use risks a doping violation.

Should I buy them online?

No. Online products are typically unregulated with no guarantee of contents or purity. Any use should be through a licensed medical provider and pharmacy.

Medical disclaimer This article is for general education and is not medical advice, a recommendation, or a protocol. CJC-1295 and Ipamorelin are unapproved substances; never obtain or use them without physician supervision.

About the author

Dr. Anouk Tans is Medical Director at My-Health, a physician-led longevity and preventive-health service in Dubai. All medical care is provided by practitioners licensed by the Dubai Health Authority (DHA), delivered to your home.